Product Information
GNP ANTI-ITCH 2%-0.1% CREAM is a generic product labeled by AmerisourceBergen, priced at $0.0575 per GM under NDC 46122080436. Its NADAC has been published 36 times since Jan 28, 2026.
Strength
2; .1 g/100g; g/100g
Manufacturer
AmerisourceBergenNDC
46122080436
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DIPHENHYDRAMINE HCL; ZINC ACETATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M017On Market Since
6/1/2025
Pharmacological Classes
Price Statistics
The NADAC for GNP ANTI-ITCH 2%-0.1% CREAM has been published 36 times since Jan 28, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0575 per GM |
|---|---|
| All-time high | $0.0581 (Jul 15, 2026) |
| All-time low | $0.0567 (Mar 18, 2026) |
| 52-week high | $0.0581 |
| 52-week low | $0.0567 |
| Median price | $0.0573 |
| Average price | $0.0573 |
| Largest weekly change | -2.4% (Jul 22, 2026) |
| Weeks tracked | 36 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diphenhydramine hydrochloride, Zinc acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diphenhydramine hydrochloride, Zinc acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Copper Absorption Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP ANTI-ITCH 2%-0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for GNP ANTI-ITCH 2%-0.1% CREAM, manufactured by AmerisourceBergen, is $0.0575 per GM (NDC 46122080436), effective Sep 30, 2026.
How has the price of GNP ANTI-ITCH 2%-0.1% CREAM changed over time?
Over the history we have for it, the NADAC for GNP ANTI-ITCH 2%-0.1% CREAM has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for GNP ANTI-ITCH 2%-0.1% CREAM?
Since Jan 28, 2026, the NADAC for GNP ANTI-ITCH 2%-0.1% CREAM has ranged from a low of $0.0567 (Mar 18, 2026) to a high of $0.0581 (Jul 15, 2026), with a median of $0.0573 per GM.
Are there cheaper alternatives to GNP ANTI-ITCH 2%-0.1% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of GNP ANTI-ITCH 2%-0.1% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP ANTI-ITCH 2%-0.1% CREAM?
GNP ANTI-ITCH 2%-0.1% CREAM (NDC 46122080436) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.